SCHEMBL23975202

SCHEMBL23975202

c1ccc(N(c2ccccc2)c2ccc3oc4c(N(c5ccccc5)c5ccccc5)c5ccccc5c(N(c5ccccc5)c5ccccc5)c4c3c2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.35
CYP3A4 P08684 2/20 0.35
MAPT P10636 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
MEN1 O00255 1/20 0.35
ALPI P09923 1/20 0.35
GAA P10253 1/20 0.35
PKM P14618 1/20 0.35
HPGD P15428 1/20 0.35
CASP3 P42574 1/20 0.35
RECQL P46063 1/20 0.35
BLM P54132 1/20 0.35
CASP7 P55210 1/20 0.35
CASP6 P55212 1/20 0.35
KMT2A Q03164 1/20 0.35
MCL1 Q07820 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19308039 0.90 MAPT (0.40) KDM4ECYP3A4MAPTL3MBTL1MEN1
SCHEMBL23975285 0.88 TDP1 (0.33) KDM4ECYP3A4MAPTL3MBTL1MEN1
SCHEMBL15851536 0.86 KDM5A (0.36) KDM4ECYP3A4MAPTL3MBTL1MEN1
SCHEMBL15851595 0.83 CYP1A2 (0.36) KDM4ECYP3A4MAPTL3MBTL1MEN1
SCHEMBL15851561 0.82 PLA2G2A (0.37) KDM4ECYP3A4MAPTL3MBTL1MEN1
SCHEMBL15851521 0.82 MEN1 (0.36) KDM4ECYP3A4MAPTL3MBTL1MEN1
SCHEMBL15851539 0.82 PLA2G2A (0.36) KDM4ECYP3A4MAPTL3MBTL1MEN1
SCHEMBL15851559 0.81 GABRP (0.35) KDM4ECYP3A4MAPTL3MBTL1MEN1
SCHEMBL15851529 0.81 KDM4E (0.36) KDM4EMAPTMEN1HPGDCASP3
SCHEMBL19887104 0.81 ALDH1A1 (0.42) KDM4ECYP3A4MAPTL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210340103-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC APPARATUS THEREOF DUK SAN NEOLUX CO., LTD (KR) 2021-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210340103-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC APPARATUS THEREOF OR51E2, SLC39A11, WEE1 KDM4E 1772/4885CYP3A4 1518/4885MAPT 1837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.